Dr. Richard C. Becker, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Cincinnati College of Medicine (1982)
- Years since graduation
- 44
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 546
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1982Medical school: University of Cincinnati College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
OH license 35 050507 · NC license T-02065
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Cincinnati Medical Center, LLC Cincinnati, OH
- West Chester Hospital West Chester, OH
Medical groups
- University of Cincinnati Physicians Company LLC (1,506 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 546
- Services billed
- 820
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 196 | 159 |
| Established patient office or other outpatient visit, 30-39 minutes | 112 | 74 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 51 | 21 |
| Established patient office or other outpatient visit, 20-29 minutes | 30 | 27 |
| New patient office or other outpatient visit, 45-59 minutes | 12 | 12 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 12 | 12 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 11 | 11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Cincinnati, OH | 87 |
| Eliquis (apixaban) Other prescribers in Cincinnati, OH | 59 |
| Atorvastatin Calcium Other prescribers in Cincinnati, OH | 45 |
| Lisinopril Other prescribers in Cincinnati, OH | 38 |
| Amlodipine Besylate Other prescribers in Cincinnati, OH | 30 |
| Metoprolol Tartrate Other prescribers in Cincinnati, OH | 30 |
| Repatha Sureclick (evolocumab) Other prescribers in Cincinnati, OH | 29 |
| Hydralazine Hcl Other prescribers in Cincinnati, OH | 26 |
| Xarelto (rivaroxaban) Other prescribers in Cincinnati, OH | 25 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Cincinnati, OH | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 3 payments worth $8,300 in total to this clinician.
| Ionis Pharmaceuticals, Inc. | $5,900 |
|---|---|
| AstraZeneca UK Limited | $2,400 |
| Consulting Fee | $8,300 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ionis Pharmaceuticals, Inc. Dec 17, 2025 | Consulting Fee TRYNGOLZA · CARDIOLOGY | $3,300 |
| Ionis Pharmaceuticals, Inc. Jul 18, 2025 | Consulting Fee TRYNGOLZA · CARDIOLOGY | $2,600 |
| AstraZeneca UK Limited May 15, 2025 | Consulting Fee WAINUA · Cardiovascular and Metabolism | $2,400 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,828 in research payments for these studies, mostly to the institutions running them.
- Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
E.r. Squibb & Sons, L.l.c. · Completed · NCT01996865
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.